HCC
PTEN icon

Hirtle Callaghan & Co’s Patterson-UTI PTEN Stock Holding History

Hirtle Callaghan & Co’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,175
Closed -$19K – 285
2014
Q4 		$19K Hold
1,175
– – ﹤0.01% 384
2014
Q3 		$38K Hold
1,175
– – 0.01% 342
2014
Q2 		$41K Hold
1,175
– – 0.01% 380
2014
Q1 		$37K Hold
1,175
– – 0.01% 386
2013
Q4 		$30K Hold
1,175
– – ﹤0.01% 385
2013
Q3 		$25K Buy
+1,175
New +$24.1K ﹤0.01% 416

Other funds holding PTEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return

Hirtle Callaghan & Co's PTEN Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Patterson-UTI (PTEN) in Q1 2015, closing a stake of 1,175 shares — an estimated $19K sold.

Hirtle Callaghan & Co first reported a position in PTEN in Q3 2013 and held it in 6 quarters. The position peaked at $41K in Q2 2014. 258 funds tracked by Wall St. Rank hold PTEN as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Patterson-UTI position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 1,175 Patterson-UTI shares in Q1 2015, an estimated $19K.
  • Hirtle Callaghan & Co first reported a position in Patterson-UTI in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's Patterson-UTI position peaked at $41K in Q2 2014.
  • 258 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.